An insight into the burden of drug-resistant tuberculosis in children

Joana Valente Dias^{1

2}, Luís Varandas^{3

4

5}, Luzia Gonçalves^{3

6

7}, Benjamin M Kagina^{8

9}

Affiliations

¹ Institute of Hygiene and Tropical Medicine, Nova University of Lisbon, Lisbon, Portugal.
² Department of Pediatrics, Beatriz Ângelo Hospital, Loures, Portugal.
³ Global Health and Tropical Medicine, Institute of Hygiene and Tropical Medicine, Nova University of Lisbon, Lisbon, Portugal.
⁴ NOVA Medical School, Nova University of Lisbon, Lisbon, Portugal.
⁵ Department of Pediatrics, Dona Estefânia Hospital, Lisbon, Portugal.
⁶ Centre of Statistics and its Applications, University of Lisbon, Lisbon, Portugal.
⁷ z-Stat4life, Lisbon, Portugal.
⁸ Vaccines for Africa Initiative, School of Public Health, University of Cape Town, Cape Town, South Africa.
⁹ Institute of Molecular Medicine & Infectious Diseases (IDM), University of Cape Town, Cape Town, South Africa.

Joana Valente Dias et al. Acta Paediatr. 2024 Apr.

. 2024 Apr;113(4):781-782.

doi: 10.1111/apa.17120. Epub 2024 Jan 20.

Joana Valente Dias^{1

2}, Luís Varandas^{3

4

5}, Luzia Gonçalves^{3

6

7}, Benjamin M Kagina^{8

9}

¹ Institute of Hygiene and Tropical Medicine, Nova University of Lisbon, Lisbon, Portugal.
² Department of Pediatrics, Beatriz Ângelo Hospital, Loures, Portugal.
³ Global Health and Tropical Medicine, Institute of Hygiene and Tropical Medicine, Nova University of Lisbon, Lisbon, Portugal.
⁴ NOVA Medical School, Nova University of Lisbon, Lisbon, Portugal.
⁵ Department of Pediatrics, Dona Estefânia Hospital, Lisbon, Portugal.
⁶ Centre of Statistics and its Applications, University of Lisbon, Lisbon, Portugal.
⁷ z-Stat4life, Lisbon, Portugal.
⁸ Vaccines for Africa Initiative, School of Public Health, University of Cape Town, Cape Town, South Africa.
⁹ Institute of Molecular Medicine & Infectious Diseases (IDM), University of Cape Town, Cape Town, South Africa.

No abstract available

References

1. World Health Organization. Roadmap towards Ending TB in Children and Adolescents. WHO; 2018. https://www.who.int/tb/publications/2018/tb-childhoodroadmap/en/ (Accessed 01 June 2022).
1. World Health Organization. Multidrug-Resistant Tuberculosis in Children and Adolescents in the WHO European Region, Expert opinion. WHO Regional Office for Europe; 2019. https://apps.who.int/iris/bitstream/handle/10665/329395/9789289054447-en... (Accessed 01 June 2022).
1. World Health Organization. Global tuberculosis report 2022. WHO; 2022. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/globa... (Accessed 01 June 2022)
1. van den Hof S, Tursynbayeva A, Abildaev T, et al. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan. Int J Tuberc Lung Dis. 2013;17(4):526-531. doi:10.5588/ijtld.12.0703
1. Reubenson G. Pediatric drug-resistant tuberculosis: a global perspective. Paediatr Drugs. 2011;13(6):349-355. doi:10.2165/11593160-000000000-00000